journal article·2023

Pyridine-appended disulfidephospholipids enable exceptionally high drug loading and stability as a robust liposomal platform

Wei Zhu, Qi Shan, Jianing Zhao, Guangyao Lv, Zongfeng Hu, Min Liu, Lei Yao, Zhuhong Zhang, Longbing Ling

Biomaterials Science· Volume 11· Issue 14
Publisher page

Abstract

Low drug loading and instability of liposomes are two main challenges in the clinic. Herein, a liposomal platform from alternative pyridine-appended disulfidephospholipid (Pyr-SS-PC) was developed for delivering camptothecin (CPT) with high loading and stability. These Pyr-SS-PC lipids with π-π stacking open a general gate in the delivery of aromatic ring-containing drugs.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education of China), School of Pharmacy, Yantai University, Yantai 264005, China

Funding

Natural Science Foundation of Shandong Province

References (29)

Show source-provided references
1. Cheng · Angew. Chem., Int. Ed. · 2014 · 53 · 1392810.1002/anie.201408934 ↗
2. Van Meer · Nat. Rev. Mol. Cell Biol. · 2008 · 9 · 11210.1038/nrm2330 ↗
3. Allen · Adv. Drug Delivery Rev. · 2013 · 65 · 3610.1016/j.addr.2012.09.037 ↗
4. Torchilin · Nat. Rev. Drug Discovery · 2005 · 4 · 14510.1038/nrd1632 ↗
5. Eloy · Colloids Surf., B · 2014 · 123 · 34510.1016/j.colsurfb.2014.09.029 ↗
6. Shah · Adv. Drug Delivery Rev. · 2020 · 154 · 10210.1016/j.addr.2020.07.002 ↗
7. Joo · Biomaterials · 2013 · 34 · 309810.1016/j.biomaterials.2013.01.039 ↗
8. Deng · Sci. Adv. · 2020 · 6 · eaax997610.1126/sciadv.aax9976 ↗
9. Song · Angew. Chem., Int. Ed. · 2005 · 44 · 473110.1002/anie.200500980 ↗
10. Zhuang · J. Controlled Release · 2019 · 294 · 31110.1016/j.jconrel.2018.12.014 ↗
11. Ling · Int. J. Pharm. · 2017 · 526 · 1110.1016/j.ijpharm.2017.04.024 ↗
12. Ling · Chem. Commun. · 2020 · 56 · 762110.1039/D0CC03589K ↗
13. Liu · Nano Lett. · 2021 · 21 · 786210.1021/acs.nanolett.1c03089 ↗
14. Robby · Nano Today · 2021 · 39 · 10117810.1016/j.nantod.2021.101178 ↗
15. Zhang · New J. Chem. · 2019 · 43 · 1867310.1039/C9NJ05052C ↗
16. Bom · J. Med. Chem. · 2000 · 43 · 397010.1021/jm000144o ↗
17. Watanabe · J. Controlled Release · 2008 · 127 · 23110.1016/j.jconrel.2008.02.005 ↗
18. Carter · Nat. Commun. · 2014 · 5 · 110.1038/ncomms4546 ↗
19. Lyubartsev · Eur. Biophys. J. · 2005 · 35 · 5310.1007/s00249-005-0005-y ↗
20. Huang · Angew. Chem., Int. Ed. · 2009 · 121 · 421010.1002/ange.200900111 ↗
21. Moon · Nat. Mater. · 2011 · 10 · 24310.1038/nmat2960 ↗
22. Sivadasan · Molecules · 2022 · 27 · 108610.3390/molecules27031086 ↗
23. Watanabe · J. Controlled Release · 2008 · 127 · 23110.1016/j.jconrel.2008.02.005 ↗
24. Liang · Adv. Mater. · 2018 · 30 · 170696310.1002/adma.201706963 ↗
25. Luzio · Nat. Rev. Mol. Cell Biol. · 2007 · 8 · 62210.1038/nrm2217 ↗
26. Von Kleist · Cell · 2011 · 146 · 47110.1016/j.cell.2011.06.025 ↗
27. Wang · Cell Res. · 2008 · 18 · 29010.1038/cr.2008.15 ↗
28. Zhang · Angew. Chem., Int. Ed. · 2019 · 131 · 1393210.1002/ange.201907380 ↗
29. Freyer · Br. J. Cancer · 2000 · 83 · 43110.1054/bjoc.2000.1303 ↗